NIVOLUMAB for Prophylaxis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where NIVOLUMAB was used for Prophylaxis.
Most Reported Side Effects for NIVOLUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 11,216 | 12.8% | 11,211 | 780 |
| Malignant neoplasm progression | 9,363 | 10.7% | 5,146 | 4,330 |
| Off label use | 5,208 | 5.9% | 1,240 | 1,725 |
| Diarrhoea | 4,692 | 5.4% | 623 | 2,506 |
| Fatigue | 3,709 | 4.2% | 409 | 1,425 |
| Pyrexia | 3,454 | 3.9% | 532 | 2,501 |
| Intentional product use issue | 3,297 | 3.8% | 1,461 | 827 |
| Rash | 2,816 | 3.2% | 297 | 1,131 |
| Nausea | 2,805 | 3.2% | 378 | 1,495 |
| Decreased appetite | 2,619 | 3.0% | 452 | 1,429 |
| Dyspnoea | 2,527 | 2.9% | 596 | 1,575 |
| Pneumonia | 2,281 | 2.6% | 792 | 1,676 |
| Colitis | 2,123 | 2.4% | 333 | 1,306 |
| Pneumonitis | 2,076 | 2.4% | 564 | 1,130 |
| Hypothyroidism | 1,939 | 2.2% | 267 | 946 |
Other Indications for NIVOLUMAB
Product used for unknown indication (12,733)
Malignant melanoma (10,599)
Non-small cell lung cancer (9,987)
Renal cell carcinoma (6,514)
Metastatic malignant melanoma (4,628)
Lung neoplasm malignant (4,197)
Metastatic renal cell carcinoma (3,857)
Gastric cancer (3,856)
Non-small cell lung cancer recurrent (2,703)
Renal cancer (1,756)
Other Drugs Used for Prophylaxis
PEGFILGRASTIM (7,424)
HUMAN C1-ESTERASE INHIBITOR (5,950)
DENOSUMAB (4,541)
SULFAMETHOXAZOLE\TRIMETHOPRIM (3,197)
ASPIRIN (2,083)
VALACYCLOVIR (1,574)
PANTOPRAZOLE (1,502)
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (1,444)
CLOPIDOGREL BISULFATE (1,296)
ENOXAPARIN (1,278)